We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$836M
AUM Growth
+$4.91M
Cap. Flow
-$16.6M
Cap. Flow %
-1.98%
Top 10 Hldgs %
38.74%
Holding
112
New
6
Increased
28
Reduced
28
Closed
20

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$11.9M
2
KYNB
Kyntra Bio
KYNB
+$9.69M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$9.43M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$6.67M
5
IMMU
Immunomedics Inc
IMMU
+$6.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17M
2
UNH icon
UnitedHealth
UNH
+$8.53M
3
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$5.93M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$5.75M
5
PODD icon
Insulet
PODD
+$5.61M

Sector Composition

Rank Sector Weight
1 Healthcare 85.37%
2 Industrials 2.83%
3 Technology 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
51
Zimmer Biomet
ZBH
$18.7B
$5.96M 0.71%
52,116
+2,987
+6% +$350K
IMMU
52
DELISTED
Immunomedics Inc
IMMU
$5.81M 0.69%
+418,900
New +$6.3M
EXAS
53
DELISTED
Exact Sciences
EXAS
$4.53M 0.54%
38,400
– –
FBRX icon
54
Forte Biosciences
FBRX
$1.57B
$4.48M 0.54%
+1,787
New +$5.3M
SAGE
55
DELISTED
Sage Therapeutics
SAGE
$4.47M 0.53%
24,400
-7,200
-23% -$1.23M
PODD icon
56
Insulet
PODD
$11.8B
$4.32M 0.52%
36,160
-54,700
-60% -$5.61M
COGT icon
57
Cogent Biosciences
COGT
$6.76B
$4.16M 0.5%
396,859
– –
AGIO icon
58
Agios Pharmaceuticals
AGIO
$2.14B
$3.99M 0.48%
80,000
+20,000
+33% +$1.07M
INDP icon
59
Indaptus Therapeutics
INDP
$219M
$3.81M 0.46%
392
+31
+9% +$391K
MTEM
60
DELISTED
Molecular Templates, Inc.
MTEM
$2.92M 0.35%
23,333
– –
URGN icon
61
UroGen Pharma
URGN
$2B
$2.34M 0.28%
65,063
– –
PHAS
62
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$2.31M 0.28%
+176,000
New +$2.16M
SVRA icon
63
Savara
SVRA
$1.09B
$1.76M 0.21%
741,100
-155,100
-17% -$1.38M
RDY icon
64
Dr. Reddy's Laboratories
RDY
$9.78B
$1.48M 0.18%
196,985
+98,500
+100% +$774K
ONC
65
BeOne Medicines Ltd
ONC
$34B
$1.39M 0.17%
11,227
+300
+3% +$38.1K
QURE icon
66
uniQure
QURE
$2.48B
$1.13M 0.14%
+14,500
New +$924K
BPMC
67
DELISTED
Blueprint Medicines
BPMC
$1.04M 0.12%
10,984
+6,800
+163% +$561K
FSTX
68
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.02M 0.12%
69,164
– –
TMO icon
69
Thermo Fisher Scientific
TMO
$217B
$1.01M 0.12%
3,450
-1,099
-24% -$303K
BDX icon
70
Becton Dickinson
BDX
$45.9B
$760K 0.09%
3,090
– –
HCM icon
71
HUTCHMED
HCM
$1.91B
$696K 0.08%
31,628
– –
ZLAB icon
72
Zai Lab
ZLAB
$2.14B
$439K 0.05%
12,589
– –
ABMD
73
DELISTED
Abiomed Inc
ABMD
$424K 0.05%
1,626
-20,801
-93% -$5.52M
KALV
74
DELISTED
KalVista Pharmaceuticals
KALV
$389K 0.05%
17,551
– –
KURA icon
75
Kura Oncology
KURA
$861M
$232K 0.03%
11,800
– –
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sectoral Asset Management held 112 positions worth $836M, up 0.59% from $831M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sectoral Asset Management's Q2 2019 filing shows 6 new, 28 increased, 28 reduced and 20 closed positions. Its largest new stake was Alexion Pharmaceuticals: 73,199 shares worth $9.59M. The largest sale was Celgene Corp, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 85% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q2 2019 buy was Alexion Pharmaceuticals: 73,199 shares worth $9.59M.
  • Sectoral Asset Management added most to Tandem Diabetes Care in Q2 2019, an estimated $11.9M increase.
  • Sectoral Asset Management's biggest Q2 2019 reduction was Insulet, cutting an estimated $5.61M.
  • Sectoral Asset Management fully exited Celgene Corp in Q2 2019, selling an estimated $17M.
  • Sectoral Asset Management's ten largest holdings make up 39% of its $836M portfolio in Q2 2019.
  • Sectoral Asset Management opened 6 new positions and closed 20 in Q2 2019.
  • Sectoral Asset Management's portfolio value rose 0.59% quarter-over-quarter to $836M.

Based on Sectoral Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.